Medicare to Cover FDA-Approved Alzheimer’s Drug Leqembi
The Food and Drug Administration (FDA) has given full approval to an Alzheimer’s treatment…
FDA Approves Alzheimer’s Drug Leqembi
On January 6, 2023, the Food and Drug Administration (FDA) approved a new Alzheimer’s…
NCMS Foundation Webinar: Treating Hepatitis C in Patients with Substance Use Disorders
Register now for the webinar: "Treating Hepatitis C in Patients with Substance Use…